MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism

Por Paquette, Melanie A., Anderson, Akari M., Lewis, Jason R., Meshul, Charles K., Johnson, Steven W., Berger, S. Paul
Publicado em 2010